Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The study will assess the duration of protection of single doses of 2 different long acting
muscarinic antagonists against methacholine induced bronchoconstriction.